MedPacto, Inc. (KOSDAQ:235980)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,880.00
-80.00 (-2.70%)
Aug 12, 2026, 1:44 PM KST

MedPacto Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,7853,898----
Revenue Growth
1012.94%-----
Gross Profit
536.2385.16----
Operating Income
-14,410-14,044-21,807-28,752-37,246-29,459
Net Income
-13,212-12,811-20,140-35,325-35,753-17,040
Earnings Per Share
-383.85-373.76-598.00-1665.00-1075.00-832.30
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
37,78740,69955,47972,60496,954121,573
Total Debt
1,6211,7251,9412,42763,37775,603
Net Cash (Debt)
36,16738,97353,53870,17733,57745,970
Net Cash Growth
-29.92%-27.20%-23.71%109.00%-26.96%2.47%
Net Cash Per Share
1049.871137.071589.633307.461009.582245.36

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-12,921-13,390-16,559-26,301-29,614-25,153
Capital Expenditures
-132.52-91.25-313.89-100.64-877.63-756.56
Free Cash Flow
-13,054-13,481-16,873-26,402-30,491-25,909
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
11.21%9.88%----
Operating Margin
-301.14%-360.24%----
Pretax Margin
-276.11%-328.61%----
Profit Margin
-276.11%-328.61%----
FCF Margin
-272.81%-345.80%----

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-51.7751.7751.7751.7751.77
PS Ratio
21.2058.73----